Bogle Investment Management’s AngioDynamics ANGO Stock Holding History

Bogle Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-40,983	Closed	-$427K	–	313
2020 Q1	$427K	Buy	+40,983	New	+$514K	0.04%	208
2017 Q4	–	Sell	-43,287	Closed	-$739K	–	285
2017 Q3	$739K	Sell	43,287 -2,710	-6%	-$45.5K	0.05%	251
2017 Q2	$745K	Sell	45,997 -13,922	-23%	-$220K	0.05%	241
2017 Q1	$1.04M	Sell	59,919 -152,975	-72%	-$2.56M	0.07%	218
2016 Q4	$3.59M	Buy	212,894 +142,939	+204%	+$2.38M	0.25%	126
2016 Q3	$1.23M	Buy	+69,955	New	+$1.13M	0.09%	234
2016 Q2	–	Sell	-67,327	Closed	-$827K	–	379
2016 Q1	$827K	Sell	67,327 -45,788	-40%	-$506K	0.06%	287
2015 Q4	$1.37M	Buy	113,115 +92,199	+441%	+$1.14M	0.1%	236
2015 Q3	$275K	Buy	+20,916	New	+$316K	0.02%	339

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Bogle Investment Management's ANGO Position: Q2 2020 in Review

Bogle Investment Management sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 40,983 shares — an estimated $427K sold.

Bogle Investment Management first reported a position in ANGO in Q3 2015 and held it in 9 quarters. The position peaked at $3.59M in Q4 2016. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

Bogle Investment Management reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
Bogle Investment Management sold 40,983 AngioDynamics shares in Q2 2020, an estimated $427K.
Bogle Investment Management first reported a position in AngioDynamics in Q3 2015 and held it in 9 quarters.
Bogle Investment Management's AngioDynamics position peaked at $3.59M in Q4 2016.
146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.